August 24–25, 2026 | Hong Kong, China
Alex Aliper, PhD, Co-founder and President of Insilico Medicine, has been invited to attend the Global Unicorn Summit in Hong Kong on August 24. He will participate in a panel discussion titled "What Will Power the Next Wave of Global Growth?" from 15:00 to 15:50.
As a leading frontier technology unicorn, Insilico Medicine is committed to redefining the drug discovery process through generative AI. Drawing on Insilico’s practical experience in advancing internal pipelines, driving international commercialization, and expanding its global footprint, Dr. Aliper will share insights on how cutting-edge technological innovation can be transformed into tangible momentum for industrial growth.
About Global Unicorn Summit
The Global Unicorn Summit is a high-level platform connecting unicorns, technology companies, investors, research institutions, and government agencies worldwide.
The Summit focuses on AI, biomedicine, new energy, advanced materials, fintech, robotics, smart vehicles, and semiconductors. Through forums, exhibitions, roadshows, matchmaking, and competitions, the Summit connects innovation with capital and industry.
Leveraging Hong Kong’s strengths as an international financial and innovation hub, it aims to build a globally recognized platform for unicorn exchange and cooperation.
August 26–28, 2026 | Hong Kong, China
Alex Aliper, PhD, Co-founder and President of Insilico Medicine, has been invited to attend the MedTech World Asia summit in Hong Kong on August 27. He will deliver remarks and join a panel discussion titled "AI & Precision Medicine: Turning Data into Targeted Care" from 12:35 to 13:10. Subsequently, Dr.Aliper will attend a luncheon titled "Cross-Border Exit Architecture for Asian MedTech Companies" on August 28, from 12:45 pm to 13:45 pm.
Drawing on Insilico’s successful applications of its proprietary generative AI platform across target discovery, biomarker identification, and clinical pipeline advancement, Dr. Aliper will share real-world case studies and industry challenges in applying AI to precision medicine. He will also join fellow experts to explore how technological innovation and industry synergy can drive the future of personalized healthcare.
About MedTech World Asia
MedTech World Asia is a premier global conference dedicated to driving innovation and collaboration in the medical technology, digital health, and healthcare sectors. Bringing together leading healthcare innovators, startups, venture capitalists, industry executives, and regulatory experts, the summit serves as a vital platform for transforming the healthcare landscape across the Asian region and beyond.
The event focuses on key emerging areas, including AI in healthcare, digital health solutions, smart medical devices, telemedicine, and healthcare investment. Through insightful keynote presentations, interactive panel discussions, startup pitch competitions, and targeted networking sessions, MedTech World Asia bridges the gap between breakthrough technology and investment, empowering healthcare companies to scale globally and build a more resilient healthcare ecosystem.